Posters from the following categories are included:

• 605. Molecular Pharmacology, Drug Resistance—Lymphoid and Other Diseases
• 612. Acute Lymphoblastic Leukemia: Clinical Studies
• 614. Acute Lymphoblastic Leukemia: Therapy, excluding Transplantation
• 618. Acute Lymphoblastic Leukemia: Biology, Cytogenetics, and Molecular Markers in Diagnosis and Prognosis
• 621. Lymphoma—Genetic/Epigenetic Biology
• 622. Lymphoma Biology—Non-Genetic Studies
• 623. Mantle Cell, Follicular, and Other Indolent B-Cell Lymphoma—Clinical Studies
• 624. Hodgkin Lymphoma and T/NK Cell Lymphoma—Clinical Studies
• 625. Lymphoma: Pre-Clinical—Chemotherapy and Biologic Agents
• 626. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Prospective Clinical Trials
• 627. Aggressive Lymphoma (Diffuse Large B-Cell and Other Aggressive B-Cell Non-Hodgkin Lymphomas)—Results from Retrospective/Observational Studies
• 641. CLL: Biology and Pathophysiology, excluding Therapy
• 642. CLL: Therapy, excluding Transplantation